Log in to save to my catalogue

Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma

Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9373823

Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma

About this item

Full title

Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma

Publisher

Wyoming: Ivyspring International Publisher Pty Ltd

Journal title

Theranostics, 2022-01, Vol.12 (13), p.5615-5630

Language

English

Formats

Publication information

Publisher

Wyoming: Ivyspring International Publisher Pty Ltd

More information

Scope and Contents

Contents

Background: Antibodies targeting surface expressed disialoganglioside GD2 are increasingly used in neuroblastoma immunotherapy and might also have potential for use in radioimmunotherapy. As such targeted treatments might benefit from a dedicated theranostic approach, we studied the influence of radiolabeling on the binding characteristics of ch14....

Alternative Titles

Full title

Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9373823

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9373823

Other Identifiers

ISSN

1838-7640

E-ISSN

1838-7640

DOI

10.7150/thno.56736

How to access this item